Novo Nordisk rebrands to Novo, signals strategic shift

Novo Nordisk, maker of Ozempic, announced a corporate rebrand to 'Novo' and a cultural update. This is a corporate identity change with potential implications for brand equity and market positioning, but no immediate financial or operational impact disclosed.